1. Liang, Shuang, Xing, Manyu, Chen, Xiang, Song, Zongbin, Zou, Wangyuan. 2022. Predicting the prognosis in patients with sepsis by a pyroptosis-related gene signature. In Frontiers in immunology, 13, 1110602. doi:10.3389/fimmu.2022.1110602. https://pubmed.ncbi.nlm.nih.gov/36618365/
2. Wen, Xiulin, Du, Huicong, Hao, Xiaoyan, Wang, Jingrong, Guo, Yuan. 2022. Expression of the GZMB Gene Polymorphism, SNP rs8192917, in 990 Han Chinese Patients with Postoperative Keloids. In Medical science monitor : international medical journal of experimental and clinical research, 28, e936963. doi:10.12659/MSM.936963. https://pubmed.ncbi.nlm.nih.gov/35733327/
3. Zhang, Yue, Cai, Xingbo, Wang, Bin, Zhang, Bihuan, Xu, Yongqing. 2023. Exploring the molecular mechanisms of the involvement of GZMB-Caspase-3-GSDME pathway in the progression of rheumatoid arthritis. In Molecular immunology, 161, 82-90. doi:10.1016/j.molimm.2023.07.013. https://pubmed.ncbi.nlm.nih.gov/37531918/
4. Liang, Zhuoshuai, Pan, Lingfeng, Shi, Jikang, Zhang, Lianbo. 2022. C1QA, C1QB, and GZMB are novel prognostic biomarkers of skin cutaneous melanoma relating tumor microenvironment. In Scientific reports, 12, 20460. doi:10.1038/s41598-022-24353-9. https://pubmed.ncbi.nlm.nih.gov/36443341/
5. Oboshi, Wataru, Watanabe, Toru, Hayashi, Keisuke, Nakamura, Takehiro, Yukimasa, Nobuyasu. 2017. QPY/RAH haplotypes of the GZMB gene are associated with natural killer cell cytotoxicity. In Immunogenetics, 70, 29-36. doi:10.1007/s00251-017-1014-6. https://pubmed.ncbi.nlm.nih.gov/28653095/